<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <link rel="stylesheet" href="style.css" />
    <title>Publications</title>
  </head>
  <body>
    <div class="container">
      <div class="column">
        <details>
          <summary>
            <span class="summary-title">2023</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Hardman et al.
              <a
                href="https://www.drugsincontext.com/the-future-of-clinical-trials-and-drug-development-2050/"
                >"The future of clinical trials and drug development": 2050</a
              >. Drugs Context
            </p>
            <p>
              Eastwood et al.
              <a
                href="https://www.jaci-inpractice.org/article/S2213-2198(22)01332-0/fulltext/"
                >A Randomized Trial of a Composite T2-Biomarker Strategy
                Adjusting Corticosteroid Treatment in Severe Asthma</a
              >: A Post Hoc Analysis by Sex.
            </p>
            <p>
              Quing et al.
              <a
                href="https://www.jacionline.org/article/S0091-6749(23)00751-0/fulltext/"
                >Blood transcriptomic signature in type-2 biomarker-low severe
                asthma and asthma control</a
              >. J Allergy Clin Immunol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2022</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Efimov et al.
              <a href="https://doi.org/10.7573/dic.2022-1-1"
                >Open-label use of an aliphatic polyamine immunomodulator in
                patients hospitalized with COVID-19"</a
              >. Drugs Context
            </p>
            <p>
              Kompier et al.
              <a href="https://f1000research.com/articles/11-259/v2"
                >Analysis of the safety and immunogenicity profile of an
                azoximer bromide polymer-adjuvanted subunit influenza
                vaccine"</a
              >. f1000Research
            </p>
            <p>
              Busby et al.
              <a href="https://erj.ersjournals.com/content/59/4/2100768"
                >Factors affecting adherence with treatment advice in a clinical
                trial of patients with severe asthma"</a
              >. ERJ
            </p>
            <p>
              McDowell et al.
              <a
                href="https://www.atsjournals.org/doi/10.1164/rccm.202201-0129OC"
                >Exacerbation Profile and Risk Factors in a Type-2–Low Enriched
                Severe Asthma Cohort: A Clinical Trial to Assess Asthma
                Exacerbation Phenotypes</a
              >. Am J Resp Crit Care Med
            </p>
            <p>
              Hardman et al.
              <a
                href="https://journal.emwa.org/a-virtual-workforce/changes-to-working-practices-in-medical-communications-during-the-covid-19-pandemic-insights-from-two-surveys/"
                >Changes to working practices in medical communications during
                the COVID-19 pandemic: Insights from two surveys</a
              >. Medical Writing
            </p>
            <p>
              Harrison et al.
              <a href="https://www.researchsquare.com/article/rs-1118410/v1"
                >Impact of the COVID-19 Pandemic on Clinical Trial Conduct:
                Lessons for the Future</a
              >. f1000Research
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2021</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Nar et al.
              <a
                href="https://chemistry-europe.onlinelibrary.com/doi/10.1002/cmdc.202000921"
                target="_blank"
                rel="nofollow"
                >Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main
                Protease."</a
              >
              ChemMedChem
            </p>
            <p>
              Gomez-Cabrero et al.
              <a
                href="https://link.springer.com/article/10.1007/s11357-021-00334-0"
                target="_blank"
                rel="nofollow"
                >A robust machine learning framework to identify signatures for
                frailty: a nested case-control study in four aging European
                cohorts.</a
              >
              GeroScience
            </p>
            <p>
              Efimov et al.
              <a
                href="https://www.drugsincontext.com/the-effect-of-azoximer-bromide-polyoxidonium-in-patients-hospitalized-with-coronavirus-disease-covid-19-an-open-label-multicentre-interventional-clinical-study/"
                target="_blank"
                rel="nofollow"
                >The effect of azoximer bromide (Polyoxidonium®) in patients
                hospitalized with coronavirus disease (COVID-19): an open-label,
                multicentre, interventional clinical study."</a
              >
              Drugs Context
            </p>
            <p>
              Hardman et al.
              <a
                href="https://journal.emwa.org/social-media/challenges-of-working-from-home-during-the-covid-19-pandemic-a-survey-to-inform-working-practices/"
                target="_blank"
                rel="nofollow"
                >Challenges of working from home during the COVID-19 pandemic: A
                survey to inform working practices."</a
              >
              Medical Writing
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2020</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Heaney, et al.
              <a href="https://google.com" target="_blank" rel="nofollow"
                >Composite type-2 biomarker strategy versus a symptom–risk-based
                algorithm to adjust corticosteroid dose in patients with severe
                asthma</a
              >: a multicentre, single-blind, parallel group, randomised
              controlled trial." Lancet Resp Med
            </p>
            <p>
              Late Breaking Abstract -
              <a href="https://google.com" target="_blank" rel="nofollow"
                >Corticosteroid optimisation in severe asthma using composite
                biomarkers to adjust dose versus a symptom/risk-based algorithm
                E-POSTER Nr 4618"</a
              >
            </p>
            <p>
              Hardman et al.
              <a
                href="https://journals.lww.com/cardiovascularendocrinology/fulltext/2020/03000/ten_tips_for_promoting_your_research.6.aspx"
                target="_blank"
                rel="nofollow"
                >Ten tips for promoting your research."</a
              >
              Cardiovasc Endocrinol Metab
            </p>
            <p>
              Rengelshausen et al.
              <a
                href="https://link.springer.com/article/10.1007/s43441-021-00257-0"
                target="_blank"
                rel="nofollow"
                >How to Interpret an Investigator’s Brochure for Meaningful Risk
                Assessment</a
              >: Results of an AGAH Discussion Forum.
            </p>
            <p>
              Tancoš et al.
              <a
                href="https://www.pathologyjournal.rcpa.edu.au/article/S0031-3025(20)30818-7/fulltext"
                target="_blank"
                rel="nofollow"
                >Programmed death ligand 1 protein expression, histological
                tumour differentiation, and intratumoural heterogeneity in
                pulmonary adenocarcinoma."</a
              >
              Pathology
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2019</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Rodriguez‐Mañas et al.
              <a
                href="https://doi.org/10.1002/jcsm.12432"
                target="_blank"
                rel="nofollow"
                >Effectiveness of a multimodal intervention in functionally
                impaired older people with type 2 diabetes mellitus.</a
              >
              Journal of Cachexia Sarco Musc
            </p>
            <p>
              Breithaupt-Grögler et al.
              <a
                href="https://doi.org/10.3389/fphar.2019.00398"
                target="_blank"
                rel="nofollow"
                >The New First-in-Human EMA Guideline</a
              >: Disruptive or Constructive? Outcomes From the First EUFEMED
              Discussion Forum.
            </p>
            <p>
              Hardman et al.
              <a
                href="https://www.frontiersin.org/articles/10.3389/fphar.2019.01377/full"
                target="_blank"
                rel="nofollow"
                >European Federation for Exploratory Medicines Development Lyon
                Conference 2019</a
              >: The Changing Landscape of Early Medicines Development—Be
              Prepared. Frontiers Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2018</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Coughlan et al.
              <a href="https://google.com" target="_blank" rel="nofollow"
                >A Prospective, Randomized, Multicenter Study Comparing
                Silicated Calcium Phosphate versus BMP-2 Synthetic Bone Graft in
                Posterolateral Instrumented Lumbar Fusion for Degenerative
                Spinal Disorders</a
              >. Spine
            </p>
            <p>
              <a
                href="https://doi.org/10.18103/mra.v6i6.1760"
                target="_blank"
                rel="nofollow"
                >A Comparative Review of Frailty Models and a description of the
                European-wide FRAILOMIC Initiative</a
              >: designed to promote Healthy Aging. Med Res Arch
            </p>
            <p>
              Hanratty et al.
              <a
                href="https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2384-7"
                target="_blank"
                rel="nofollow"
                >A randomised pragmatic trial of corticosteroid optimization in
                severe asthma using a composite biomarker algorithm to adjust
                corticosteroid dose versus standard care</a
              >: study protocol for a randomized trial. Trials
            </p>
            <p>
              Van Bortel et al.
              <a
                href="https://www.frontiersin.org/articles/10.3389/fphar.2017.00901/full"
                target="_blank"
                rel="nofollow"
                >EUFEMED London Conference 2017: Exploratory Medicines
                Development Innovation and Risk Management</a
              >. Frontiers Pharmacol
            </p>
            <p>
              Reijntjes et al.
              <a
                href="https://www.frontiersin.org/articles/10.3389/fphar.2018.01301/full"
                target="_blank"
                rel="nofollow"
                >The Association for Human Pharmacology in the Pharmaceutical
                Industry London Meeting 2018</a
              >: Brexit and Other Challenges in Early Phase Drug Development.
              Frontiers Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2017</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Fellström et al. Targeted-release budesonide versus placebo in
              patients with IgA nephropathy (NEFIGAN): a double-blind,
              randomized, placebo-controlled phase 2b trial. The Lancet (no
              link)
            </p>
            <p>
              Hardman and Serginson.
              <a
                href="https://journals.lww.com/cardiovascularendocrinology/fulltext/2017/09000/ready__aim__fire__targeting_the_right_medical.2.aspx"
                target="_blank"
                rel="nofollow"
                >Ready! Aim! Fire! targeting the right medical science
                journal</a
              >. J Cardiovasc Endocrinol
            </p>
            <p>
              Van Bortel et al.
              <a
                href="https://www.frontiersin.org/books/EUFEMED_2017/1195"
                target="_blank"
                rel="nofollow"
                >Integration of ICH E4 cardiac safety in first time in man and
                other Phase I healthy volunteer studies</a
              >. Frontiers Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2016</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Zeitlinger et al. Simultaneous assessment of the pharmacokinetics
              of a pleuromutilin, lefamulin, in plasma, soft tissues and
              pulmonary epithelial lining fluid. J Antimicrob Chemother (no
              link)
            </p>
            <p>
              Heaney et al.
              <a
                href="https://thorax.bmj.com/content/71/2/187"
                target="_blank"
                rel="nofollow"
                >Research in progress: Medical Research Council United Kingdom
                Refractory Asthma Stratification Programme (RASP-UK)</a
              >.
            </p>
            <p>
              Emmanual et al. Constipation in older people: A consensus
              statement. Int J Clinical Practice
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2015</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Berlin et al. EP3/FP dual receptor agonist ONO-9054 administered
              morning or evening to patients with open-angle glaucoma or ocular
              hypertension: results of a randomized crossover study. Br J
              Ophthalmol
            </p>
            <p>
              Reijntjes S et al.
              <a
                href="https://academic.oup.com/pmj/article-abstract/90/1068/582/6992124?redirectedFrom=fulltext"
                target="_blank"
                rel="nofollow"
                >Bariatric surgery in obese older people</a
              >: Useful or not? Cardiovasc Endocrinol
            </p>
            <p>
              Everson et al. Sofosbuvir With Velpatasvir in Treatment-Naive
              Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus
              Infection. Annals Int Med
            </p>
            <p>
              Lawitz et al. A phase 1, randomized, dose-ranging study of
              GS-5816, a once-daily NS5A inhibitor, in patients with genotype
              1–4 hepatitis C virus. J Viral Hep
            </p>
            <p>
              Molina et al. Sofosbuvir plus ribavirin for treatment of hepatitis
              C virus in patients co-infected with HIV (PHOTON-2): a
              multicentre, open-label, non-randomized, phase 3 study. The Lancet
            </p>
            <p>
              Planko et al. Sofosbuvir Plus Velpatasvir Combination Therapy for
              Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C
              Virus Infection. Ann Int Med
            </p>
            <p>
              Smucker et al. Assessment of sicap-30 in a rabbit posterolateral
              fusion model with concurrent chemotherapy. The Iowa Orthop J
            </p>
            <p>
              Eastell et al. Morning vs evening dosing of the cathepsin K
              inhibitor ONO-5334: effects on bone resorption in postmenopausal
              women in a randomized, phase 1 trial. Osteoporos Int
            </p>
            <p>
              Suto et al. Safety, tolerability, and pharmacokinetic profile of
              the novel translocator protein 18kDa antagonist ONO-2952 in
              healthy volunteers. Clin Therap
            </p>
            <p>
              Vidall et al. Impact and management of
              chemotherapy/radiotherapy-induced nausea and vomiting and the
              perceptual gap between oncologists/oncology nurses and patients: a
              cross-sectional multinational survey. Supp Care Cancer
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2014</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Eastell et al. Effect of ONO‐5334 on Bone Mineral Density and
              Biochemical Markers of Bone Turnover in Postmenopausal
              Osteoporosis: 2‐Year Results From the OCEAN Study. J Bone Min Res
            </p>
            <p>
              Dubrey et al.
              <a
                href="https://academic.oup.com/pmj/article-abstract/90/1068/582/6992124?redirectedFrom=fulltext"
                target="_blank"
                rel="nofollow"
                >Sarcoidosis: The links between epidemiology and aetiology</a
              >. Med J
            </p>
            <p>
              Rodriguez‐Mañas et al.
              <a
                href="https://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-15-34"
                target="_blank"
                rel="nofollow"
                >An evaluation of the effectiveness of a multi-modal
                intervention in frail and pre-frail older people with type 2
                diabetes - the MID-Frail study</a
              >: Study protocol for a randomized controlled trial. Trials
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2013</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Hardman and Dubrey.
              <a
                href="https://www.magonlinelibrary.com/doi/abs/10.12968/hmed.2013.74.4.202"
                target="_blank"
                >New therapies in the management of type 2 diabetes</a
              >. Br J Hosp Med
            </p>
            <p>
              Wierzbicki et al.
              <a
                href="https://journals.lww.com/co-cardiology/abstract/2013/07000/new_therapies_to_reduce_low_density_lipoprotein.12.aspx"
                target="_blank"
                >New therapies to reduce low-density lipoprotein cholesterol</a
              >. Current Op Cardiol
            </p>
            <p>
              Follows et al. Efficacy, safety and tolerability of GSK2190915, a
              5-lipoxygenase activating protein inhibitor, in adults and
              adolescents with persistent asthma: a randomised dose-ranging
              study. Resp Res
            </p>
            <p>
              Liu et al. A Single and Multiple Dose Study to Investigate the
              Pharmacokinetics of a Prolonged Release Formulation of Ropinirole
              in Healthy Chinese Subjects. Clin Pharmacol Drug Dev
            </p>
            <p>
              Zhang et al. The efficacy and safety of ropinirole prolonged
              release tablets as adjunctive therapy in Chinese subjects with
              advanced Parkinson’s disease: A multicenter, double-blind,
              randomized, placebo-controlled study. Parkinson Rel Dis
            </p>
            <p>
              Snowise et al. Addition of a 5-lipoxygenase-activating protein
              inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting
              beta-2-agonist combination in subjects with asthma. Current Med
              Res Opin
            </p>
            <p>
              Lopez et al. Eight weeks of supplementation with a
              multi-ingredient weight loss product enhances body composition,
              reduces hip and waist girth, and increases energy levels in
              overweight men and women. J Int Soc Sports Nut
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2012</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Berges et al. Pharmacokinetics, Safety, and Tolerability Following
              the Administration of a Single Dose of a Combination Tablet
              Containing Sumatriptan and Naproxen Sodium in Adolescent Patients
              With Migraine and in Healthy Adult Volunteers. Clin Pharmacol Drug
              Dev
            </p>
            <p>
              Doyle et al. Midodrine: use and current status in the treatment of
              hypotension. Br J Cardiol
            </p>
            <p>
              Hocher et al. Renal and Cardiac Effects of DPP‑4 Inhibitors – from
              Preclinical Development to Clinical Research. Kid Blood Press Res
            </p>
            <p>
              Dubrey et al. Cardiovascular medication in women and urinary
              continence. Geriatric Med
            </p>
            <p>
              Wierzbicki et al.
              <a
                href="https://onlinelibrary.wiley.com/doi/10.1002/fps.93"
                target="_blank"
                rel="nofollow"
                >Drugs in development for the management of dyslipidaemia</a
              >. Fut Prescriber
            </p>
            <p>
              Cameron et al. Directed osteogenic differentiation of human
              mesenchymal stem/precursor cells on silicate substituted calcium
              phosphate. J Biomed Mater Res Part A
            </p>
            <p>
              Denning et al. Pharmacokinetics, Safety, and Tolerability of
              GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C
              Virus, following Single Ascending Doses in Healthy Subjects.
              Antimicrob Agents Chemother
            </p>
            <p>
              Lawitz et al. Pharmacokinetics, Pharmacodynamics, and Tolerability
              of GS-9851, a Nucleotide Analog Polymerase Inhibitor, following
              Multiple Ascending Doses in Patients with Chronic Hepatitis C
              Infection. Antimicrob Agents Chemother
            </p>
            <p>
              Emtestam et al. Treatment of distal subungual onychomycosis with a
              topical preparation of urea, propylene glycol and lactic acid:
              results of a 24-week, double-blind, placebo-controlled study.
              Mycoses
            </p>
            <p>
              Faergemann. Kerasal nail clinical studies demonstrate early
              visible improvement in nails damaged by onychomycosis. Pod
              Management
            </p>
            <p>
              Wierzbicki et al.

              <a
                href="https://www.tandfonline.com/doi/full/10.1517/13543784.2012.679340"
                target="_blank"
                rel="nofollow"
                >Inhibition of pre-protein convertase serine kexin-9 (PCSK-9) as
                a treatment for hyperlipidaemia</a
              >. Exp Opin Inv Drugs
            </p>
            <p>
              Wierzbicki et al.

              <a
                href="https://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2011.02867.x"
                target="_blank"
                rel="nofollow"
                >New lipid-lowering drugs</a
              >: An update. Int J Clin Practice
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2011</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Sodium-Glucose Co-transporter 2 inhibitors Hardman and Dubrey.
              <a
                href="https://link.springer.com/article/10.1007/s13300-011-0004-1"
                target="_blank"
                rel="nofollow"
                >Development and potential role of Type-2 sodium-glucose
                transporter inhibitors for management of type 2 diabetes</a
              >. Diabetes Ther
            </p>
            <p>
              Hing et al. Effects of serum protein on ionic exchange between
              culture medium and microporous hydroxyapatite and
              silicate-substituted hydroxyapatite. J Mater Sci: Mater Med
            </p>
            <p>
              Campion et al. Increasing strut porosity in silicate-substituted
              calcium-phosphate bone graft substitutes enhances osteogenesis. J
              Biomed Mat Res B: App Biomat
            </p>
            <p>
              Emtestam et al. Treatment of seborrhoeic dermatitis of the scalp
              with a topical solution of urea, lactic acid, and propylene glycol
              (K301): results of two double-blind, randomised,
              placebo-controlled studies. Mycoses
            </p>
            <p>
              Esser et al. Efficacy, adherence and tolerability of once daily
              tenofovir df-containing antiretroviral therapy in former injecting
              drug users with HIV-1 receiving opiate treatment: results of a
              48-week open-label study. Eur J Med Res
            </p>
            <p>
              Daley-Yates and Parkins. Establishing bioequivalence for inhaled
              drugs; weighing the evidence. Expert Opin Drug Deliv
            </p>
            <p>
              Lister et al. Pharmacokinetics, Safety, and Tolerability of
              Ascending Doses of Sublingual Fentanyl, With and Without
              Naltrexone, in Japanese Subjects. J Clin Pharmacol
            </p>
            <p>
              Faergemann et al. Early and Visible Improvements after Application
              of K101 in the Appearance of Nails Discoloured and Deformed by
              Onychomycosis. J Cos Dermatol Sci App
            </p>
            <p>
              Lopez. Choosing the right Omega-3 supplement: Natural Triglyceride
              Omega-3 versus Synthetic Ethyl Ester.
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>
      </div>

      <div class="column">
        <details>
          <summary>
            <span class="summary-title">2010</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>

          <div class="summary-content">
            <p>
              Hardman et al.
              <a
                href="https://www.eurekaselect.com/article/13695"
                target="_blank"
                rel="nofollow"
                >Sodium-Glucose Co-transporter 2 inhibitors</a
              >: From apple tree to ‘sweet pee’. Current Pharmaceutical Design
            </p>
            <p>
              Guth et al. Surface Physiochemistry Affects Protein Adsorption to
              Stoichiometric and Silicate-Substituted Microporous
              Hydroxyapatites. Adv Eng Mat
            </p>
            <p>
              Guth et al. Effect of Silicate-Substitution on Attachment and
              Early Development of Human Osteoblast-Like Cells Seeded on
              Microporous Hydroxyapatite Discs. Adv Eng Mat
            </p>
            <p>
              Campion et al. Increasing strut porosity in silicate-substituted
              calcium-phosphate bone graft substitutes enhances osteogenesis. J
              Biomed Mat Res
            </p>
            <p>
              Lister et al. Pharmacokinetics, Safety, and Tolerability of
              Ascending Doses of Sublingual Fentanyl, With and Without
              Naltrexone, in Japanese Subjects. J Clin Pharmacol
            </p>
            <p>
              Valecha et al. An Open-Label, Randomised Study of
              Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for
              Falciparum Malaria in Asia. PLoS ONE
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2009</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Wierzbicki et al.
              <a
                href="https://www.eurekaselect.com/article/29384"
                target="_blank"
                rel="nofollow"
                >Future challenges for microsomal transport protein
                inhibitors</a
              >. Curr Vasc Pharmacol
            </p>
            <p>
              Fuchs et al. Concentration-dependent plasma protein binding of the
              novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable
              binding to its target in plasma of mice, rats and humans. J
              Pharmacy Pharmacol
            </p>
            <p>
              Rungby. Inhibition of dipeptidyl peptidase 4 by BI-1356, a new
              drug for the treatment of beta-cell failure in type 2 diabetes.
              Expert Opin Investig Drugs
            </p>
            <p>
              Klein et al. The challenge of developing novel pharmacological
              therapies for non-alcoholic steatohepatitis. Liver Int
            </p>
            <p>
              Thomas et al. Chronic Treatment with the Dipeptidyl Peptidase-4
              Inhibitor BI 1356
              [(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione]
              Increases Basal Glucagon-Like Peptide-1 and Improves Glycemic
              Control in Diabetic Rodent Models. J Pharmacol Exp Therap
            </p>
            <p>
              Daley-Yates et al. Pharmacokinetic, pharmacodynamic, efficacy, and
              safety data from two randomized, double-blind studies in patients
              with asthma and an in vitro study comparing two dry-powder
              inhalers delivering a combination of salmeterol 50 ug and
              fluticasone proprionate 250 ug: Implications of establishing
              bioequivalence of inhaled products. Clin Therap
            </p>
            <p>
              Williams et al. Effects of food and antacids on the
              pharmacokinetics of eltrombopag in healthy adult subjects: Two
              single-dose, open-label, randomized-sequence, crossover studies.
              Clin Therap
            </p>
            <p>
              Jenkins et al. Eltrombopag, an oral thrombopoietin receptor
              agonist, has no impact on the pharmacokinetic profile of probe
              drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and
              CYP2C19 in healthy men: a cocktail analysis. Eur J Clin Pharmacol
            </p>
            <p>
              Pulido et al. Long-Term Efficacy and Safety of Fosamprenavir plus
              Ritonavir Versus Lopinavir/Ritonavir in Combination with
              Abacavir/Lamivudine over 144 Weeks. HIV Clin Trials
            </p>
            <p>
              Lister et al. Pharmacokinetics, Safety, and Tolerability of
              Ascending Doses of Sublingual Fentanyl With and Without Naltrexone
              in Japanese Subjects. J Clin Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2008</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Weirzbicki et al.
              <a
                href="https://journals.sagepub.com/doi/10.1177/14746514080080030201"
                target="_blank"
                >Clinical aspects of the management of HIV lipodystrophy</a
              >. British Journal of Diab Vasc Dis
            </p>

            <p>
              Wierzbicki et al.
              <a
                href="	https://www.tandfonline.com/doi/abs/10.1185/030079908X272742"
                target="_blank"
                >HIV lipodystrophy and its metabolic consequences</a
              >: Implications for clinical practice. Current Med Res Opin
            </p>
            <p>
              Hüttner et al. Safety, Tolerability, Pharmacokinetics, and
              Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of
              Dipeptidyl Peptidase 4, in Healthy Male Volunteers. J Clin
              Pharmacol
            </p>
            <p>
              Thomas et al.
              (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-
              (4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI
              1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor,
              Has a Superior Potency and Longer Duration of Action Compared with
              Other Dipeptidyl Peptidase-4 Inhibitors. J Pharmacol Exp Therap
            </p>
            <p>
              Kassianos. Ambulatory ECG monitoring in primary care. Prim Care
              Cardiovasc J
            </p>
            <p>
              Mallal et al. HLA-B*5701 Screening for Hypersensitivity to
              Abacavir. New Eng J Med
            </p>
            <p>
              Dixon et al. Lamotrigine does not prolong QTc in a thorough QT/QTc
              study in healthy subjects. Br J Clin Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2007</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Gunthorpe et al. Characterization of SB-705498, a Potent and
              Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That
              Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of
              the Receptor. J Pharmacol Exp Therap
            </p>
            <p>
              Flood-Page et al. A Study to Evaluate Safety and Efficacy of
              Mepolizumab in Patients with Moderate Persistent Asthma. Am J
              Respir Crit Care Med
            </p>
            <p>
              McHutchison et al. Eltrombopag for Thrombocytopenia in Patients
              with Cirrhosis Associated with Hepatitis C. New Eng J Med
            </p>
            <p>
              Hoen et al. Predictors of Virological Outcome and Safety in
              Primary HIV Type 1–Infected Patients Initiating Quadruple
              Antiretroviral Therapy: QUEST GW PROB3005. Clin Infect Dis
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2006</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Ismail et al. Characterization of the metabolites of alosetron in
              experimental animals and human. Xenobiotica
            </p>
            <p>
              Felicia et al. Patterns of asthma-related health care resource use
              in children treated with montelukast or fluticasone. Current Med
              Res Opin
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2005</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Cockcroft et al. Pulse Pressure Predicts Cardiovascular Risk in
              Patients With Type 2 Diabetes Mellitus. Am J Hypertens
            </p>
            <p>
              McEwan et al. Patterns of graft and patient survival following
              renal transplantation and evaluation of serum creatinine as a
              predictor of survival: a review of data collected from one
              clinical centre over 34 years. Current Med Res Opin
            </p>
            <p>
              Kinloch–de Loes et al. Impact of Therapeutic Immunization on HIV-1
              viremia after discontinuation of antiretroviral therapy initiated
              during acute infection. J Infect Dis
            </p>
            <p>
              Hindmarch. A double-blind, placebo- and
              positive-internal-controlled (alprazolam) investigation of the
              cognitive and psychomotor profile of pregabalin in healthy
              volunteers. Psychopharmacology
            </p>
            <p>
              Hindmarch et al. A Double-Blind Study in Healthy Volunteers to
              Assess the Effects on Sleep of Pregabalin Compared with Alprazolam
              and Placebo. Sleep
            </p>
            <p>
              Kempsford et al. Comparison of the systemic pharmacodynamic
              effects and pharmacokinetics of salmeterol delivered by CFC
              propellant and non-CFC propellant metered dose inhalers in healthy
              subjects. Resp Med
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2004</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Barnett et al. A placebo-controlled crossover study comparing the
              effects of nateglinide and glibenclamide on postprandial
              hyperglycaemia and hyperinsulinaemia in patients with type 2
              diabetes. Diab Obs Metab
            </p>
            <p>
              Gathe et al. SOLO: 48-week efficacy and safety comparison of
              once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir
              in naive HIV-1-infected patients. AIDS
            </p>
            <p>
              Currie et al. Evaluation of the future supply and demand for blood
              products in the United Kingdom National Health Service.
              Transfusion Med
            </p>
            <p>
              McEwan et al. Evaluating the performance of the Framingham risk
              equations in a population with diabetes. Diabet Med
            </p>
            <p>
              Evans et al. Should we routinely measure a proxy for insulin
              resistance as well as improve our modelling techniques to better
              predict the likelihood of coronary heart disease in people with
              type 2 diabetes? For debate. Diab Obes Metab
            </p>
            <p>
              Currie et al. The financial costs of hospital care for people with
              diabetes who have single and multiple macrovascular complications.
              Diab Res Clin Pract
            </p>
            <p>
              Currie et al. Comparative estimates of the financial burden to the
              UK health system of hospital care for people with and without
              diabetes in the year before death. Diab Res Clin Pract
            </p>
            <p>
              Wood et al. A 42-week open-label study to assess the
              pharmacokinetics, antiretroviral activity, and safety of
              amprenavir or amprenavir plus ritonavir in combination with
              abacavir and lamivudine for treatment of HIV-infected patients.
              Clin Infect Dis
            </p>
            <p>
              Vibhagool et al. Triple nucleoside treatment with abacavir plus
              the lamivudine/zidovudine combination tablet (COM) compared to
              indinavir/COM in antiretroviral therapy naïve adults: results of a
              48-week open-label, equivalence trial (CNA3014). Current Med Res
              Opin
            </p>
            <p>
              MacManus et al. GW433908/ritonavir once daily in antiretroviral
              therapy-naive HIV-infected patients: absence of protease
              resistance at 48 weeks. AIDS
            </p>
            <p>
              Rodriguez-French et al. The NEAT Study: A 48-Week Open-Label Study
              to Compare the Antiviral Efficacy and Safety of GW433908 Versus
              Nelfinavir in Antiretroviral Therapy–Naïve HIV-1-Infected
              Patients. J Acquir Immune Defic Syndr
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2003</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Jones et al. Pharmacokinetics and tolerability of GW420867X, a
              Nonnucleoside Reverse Transcriptase Inhibitor, following Single
              Escalating Doses in Healthy Male Volunteers. J Clin Pharmacol
            </p>
            <p>
              Prince et al. Phase II Clinical Study of BC-3781, a Pleuromutilin
              Antibiotic, in Treatment of Patients with Acute Bacterial Skin and
              Skin Structure Infections. Ant Agents Chemotherap
            </p>
            <p>
              Anderson et al. The effect of nateglinide taken with food on
              gastric emptying rates in healthy subjects. Clin Therap
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2002</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Wierzbicki et al.
              <a
                href="https://academic.oup.com/ajh/article/15/7/633/96887"
                target="_blank"
                >The Apolipoprotein E2 Allele Modulates Activity and Maximal
                Velocity of the Sodium–Lithium Countertransporter</a
              >. Am J Hypertens
            </p>
            <p>
              Hardman et al.
              <a
                href="https://www.sciencedirect.com/science/article/abs/pii/S1056871902001880?via%3Dihub"
                target="_blank"
                >Correction for the adverse influence of sodium-potassium
                cotransport on apparent sodium-lithium countertransport activity
                in human erythrocytes</a
              >. J Pharmacol Tox Methods
            </p>
            <p>
              Falcoz et al.
              <a
                href="https://accp1.onlinelibrary.wiley.com/doi/abs/10.1177/009127002401102803"
                target="_blank"
                >Pharmacokinetics of GW433908, a prodrug of amprenavir, in
                healthy male volunteers</a
              >. Journal of Clinical Pharmacology
            </p>
            <p>
              Tilling et al. Parallel decline of CD8+ /CD38++ T cells and
              viraemia in response to quadruple highly active antiretroviral
              therapy in primary HIV infection. AIDS
            </p>
            <p>
              Jabs et al. HIV and cytomegalovirus viral load and clinical
              outcomes in AIDS and cytomegalovirus retinitis patients:
              Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS
            </p>
            <p>
              Singh et al. Pharmacokinetics and systemic effects of inhaled
              fluticasone propionate in chronic obstructive pulmonary disease.
              Br J Clin Pharmacol
            </p>
            <p>
              Andersson et al. Low Levels of Perforin Expression in CD81 T
              Lymphocyte Granules in Lymphoid Tissue during Acute Human
              Immunodeficiency Virus Type 1 Infection. Journal of Infectious
              Diseases
            </p>
            <p>
              Anderson et al. No effect of the novel antidiabetic agent
              nateglinide on the pharmacokinetics and anticoagulant properties
              of warfarin in healthy volunteers. J Clin Pharmacol
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2001</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Tilling et al. Parallel decline of CD8+ /CD38++ T cells and
              viraemia in response to quadruple highly active antiretroviral
              therapy in primary HIV infection. AIDS
            </p>
            <p>
              Jabs et al. HIV and cytomegalovirus viral load and clinical
              outcomes in AIDS and cytomegalovirus retinitis patients:
              Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS
            </p>
            <p>
              Singh et al. Pharmacokinetics and systemic effects of inhaled
              fluticasone propionate in chronic obstructive pulmonary disease.
              Br J Clin Pharmacol
            </p>
            <p>
              Andersson et al. Low Levels of Perforin Expression in CD81 T
              Lymphocyte Granules in Lymphoid Tissue during Acute Human
              Immunodeficiency Virus Type 1 Infection. Journal of Infectious
              Diseases
            </p>
            <p>
              Anderson et al. No effect of the novel antidiabetic agent
              nateglinide on the pharmacokinetics and anticoagulant properties
              of warfarin in healthy volunteers. J Clin Pharmacol
            </p>
            <p>
              Hardman et al. Apolipoprotein E gene polymorphism and
              sodium-lithium countertransport activity. Metabolism
            </p>
            <p>
              Hardman and Lunnon.
              <a
                href="https://www.tandfonline.com/doi/abs/10.1517/14656566.2.5.731"
                target="_blank"
                >The current status of antihypertensive treatments: into the new
                millennium</a
              >. Exp Opin Pharmacotherapy
            </p>

            <p>
              Moore et al.
              <a
                href="https://link.springer.com/article/10.1007/s002280000224"
                target="_blank"
                >Pharmacokinetics and safety of escalating single and repeat
                oral doses of GW420867X, a novel non-nucleoside reverse
                transcriptase inhibitor</a
              >. Eur J Clin Pharmacol
            </p>

            <p>
              Moore et al.
              <a
                href="https://accp1.onlinelibrary.wiley.com/doi/abs/10.1177/00912700122012706"
                target="_blank"
                >Pharmacokinetics and tolerability of profile of GW420867X, a
                non-nucleoside reverse transcriptase inhibitor, following single
                escalating doses in healthy male volunteers</a
              >. J Clin Pharmacol
            </p>

            <p>
              Wierzbicki et al.
              <a
                href="https://academic.oup.com/ajh/article/14/1/32/135707"
                target="_blank"
                >Relation between sodium–lithium countertransport and
                hypertriglyceridemia in Type V hyperlipidemia</a
              >. Am J Hypertens
            </p>

            <p>
              Hardman et al.
              <a href="https://www.nature.com/articles/1001198" target="_blank"
                >Erythrocyte sodium-lithium countertransport in African American
                women</a
              >. J Hum Hypertens
            </p>

            <p>
              Hardman et al.
              <a
                href="https://www.ahajournals.org/doi/10.1161/hyp.38.6.e35"
                target="_blank"
                >Sodium-lithium countertransport activity is linked to
                chromosome 5 in baboons</a
              >. Hypertens
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">2000</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Dubrey and Hardman. Natriuretic peptides and heart failure:
              diagnosis, prognosis and treatment. Br J Cardiol
            </p>
            <p>
              Wierzbicki et al.
              <a href="https://www.nature.com/articles/1001097" target="_blank"
                >Effects of lipids in patients with familial
                hypercholesterolaemia on the kinetics of the sodium-lithium
                countertransporter</a
              >. J Hum Hypertens
            </p>
            <p>
              Mallal et al. Contribution of nucleoside analogue reverse
              transcriptase inhibitors to subcutaneous fat wasting in patients
              with HIV infection. AIDS
            </p>
            <p>
              Thomas et al. Brain and CSF entry of the novel nonnucleoside
              reverse transcriptase inhibitor, GW420867X. NeuroReport
            </p>
            <p>
              Goh et al. The Quest Trial, a paradigm of HIV collaborative
              research. Nat Med
            </p>
            <p>Purdon. In bed with the enemy. Clin Res Focus</p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">1999</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Dove et al. Dual Efficacy of Lamivudine Treatment in Human
              Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a
              Randomized, Controlled Study (CAESAR). J Infect Dis
            </p>
            <p>
              Hardman et al.
              <a href="https://www.nature.com/articles/1000904" target="_blank"
                >Urinary retinol binding protein (RBP) excretion and erythrocyte
                sodium-lithium countertransport (SLC) activity in a cohort of
                healthy normotensive subjects</a
              >.
            </p>
            <p>
              Hardman et al.
              <a
                href="https://pubmed.ncbi.nlm.nih.gov/10483984/"
                target="_blank"
                >Enhanced activity of the sodium lithium countertransporter in
                patients with cardiac syndrome X</a
              >: a potential link between cardiac syndrome X and metabolic
              syndrome X.
            </p>

            <p>
              Wierzbicki et al.
              <a
                href="https://onlinelibrary.wiley.com/doi/10.1023/A%3A1005486913371"
                target="_blank"
                >Transport of phytanic acid on lipoprotein in Refsum’s
                disease</a
              >.
            </p>
            <p>
              Rippin et al. Urine pterin levels in patients with pre-cancerous
              lesions of the uterine cervix. Clin Sci
            </p>
            <p>
              Hardman et al. Erythrocyte Na+/Li+ countertransport and Na+/K+
              -2Cl- co-transport in essential hypertension. Clin Sci
            </p>
            <p>
              Wierzbicki et al.
              <a
                href="https://academic.oup.com/ajh/article/12/S3/433/224264"
                target="_blank"
                >Na,Li-Countertransport and ethnicity</a
              >.
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>

        <details>
          <summary>
            <span class="summary-title">1998</span>
            <div class="summary-chevron-up">
              <svg
                xmlns="http://www.w3.org/2000/svg"
                width="24"
                height="24"
                viewBox="0 0 24 24"
                fill="none"
                stroke="currentColor"
                stroke-width="2"
                stroke-linecap="round"
                stroke-linejoin="round"
                class="feather feather-chevron-down"
              >
                <polyline points="6 9 12 15 18 9"></polyline>
              </svg>
            </div>
          </summary>
          <div class="summary-content">
            <p>
              Hardman et al. Erythrocyte sodium lithium countertransport (SLC)
              activity and retinol binding protein (RBP) in healthy normotensive
              subjects. Clin Sci
            </p>
            <p>
              Hardman et al. Urinary retinol binding protein (RBP) excretion and
              erythrocyte sodium-lithium countertransport (SLC) activity in a
              cohort of healthy normotensive subjects. Hum Hypertens
            </p>
            <p>
              Hardman et al.
              <a
                href="https://link.springer.com/article/10.1007/s002329900326"
                target="_blank"
                >Characterization of the erythrocyte sodium-lithium
                countertransporter; limitations and assumptions of traditional
                and kinetic methodologies</a
              >.
            </p>
            <p>
              Hardman et al.
              <a
                href="https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2362.1998.00291.x"
                target="_blank"
                >Influence of plasma phytanic acid levels in Refsum’s disease on
                the behavior of the erythrocyte membrane sodium-lithium
                countertransporter</a
              >.
            </p>
            <p>
              Hardman et al.
              <a href="https://www.nature.com/articles/1000555" target="_blank"
                >Kinetic characteristics of the erythrocyte sodium-lithium
                countertransporter in black normotensive subjects compared with
                other ethnic groups</a
              >.
            </p>
            <p>
              Hardman and Wierzbicki.
              <a
                href="https://journals.lww.com/jhypertension/citation/1998/16040/cation_transport_in_bartter_s_syndrome.18.aspx"
                target="_blank"
                >Na,Li-countertransport and ethnicity</a
              >.
            </p>

            <p>
              Chalkley et al. Reductions in blood lead in school children since
              the phase-down of the use of lead in petrol. Clin Sci
            </p>
            <p>
              Chalkley et al. Iron deficiency in a cohort of school children
              living within the inner-city London area. Clin Sci
            </p>

            <p>
              Hardman et al.
              <a
                href="https://portlandpress.com/clinsci/article-abstract/94/s38/12P/106015/Comparison-of-Traditional-amp-Bicarbonate-Lithium?redirectedFrom=fulltext"
                target="_blank"
                >Comparison of traditional and bicarbonate lithium loading
                methods on the characteristics of the sodium-lithium
                countertransporter (SLC).</a
              >
            </p>
            <p>
              Wierzbicki et al. Transport of phytanic acid on lipoproteins in
              Refsum’s disease. Clin Sci
            </p>
            <p>
              Wierzbicki et al. Sodium-lithium countertransport in patients with
              Refsum’s disease. Clin Sci
            </p>
            <p>
              Chalkley et al. Effects of exposure to lead and cadmium on
              metabolism of vitamin D3 in smelter workers. Clin Sci
            </p>
            <p>
              Hardman et al. Influence of plasma phytanic acid levels in
              Refsum’s disease on the behavior of the erythrocyte membrane
              sodium-lithium countertransporter. Clin Sci
            </p>
            <p>
              Wierzbicki et al.
              <a
                href="https://academic.oup.com/ajh/article/11/S3/156A/116945"
                target="_blank"
                >Triglyceride not insulin resistance principally determines
                sodium-lithium countertransport activity in patients with
                hyperchylomicronaemia.</a
              >
            </p>
            <p>
              Chalkley et al. Benign Hyperbilirubinaemia in Tuvaluan
              Schoolchildren. Clin Sci
            </p>
            <p>
              Chalkley et al. Relationship of Mean Cell Volume and Blood Lead in
              London Schoolchildren at Low Lead Levels. Clin Sci
            </p>
            <p>
              Hardman et al. Erythrocyte sodium-lithium countertransport (SLC)
              activity and retinol binding protein (RBP) excretion in healthy
              normotensive subjects. Clin Sci
            </p>
            <p>
              Chalkley et al. Blood lead levels and indices of anemia in London
              schoolchildren. Clin Sci
            </p>
            <p>
              Hardman et al. Cation transport in Bartter’s syndrome. J Hypertens
            </p>
          </div>
          <div class="summary-chevron-down">
            <svg
              xmlns="http://www.w3.org/2000/svg"
              width="24"
              height="24"
              viewBox="0 0 24 24"
              fill="none"
              stroke="currentColor"
              stroke-width="2"
              stroke-linecap="round"
              stroke-linejoin="round"
              class="feather feather-chevron-up"
            >
              <polyline points="18 15 12 9 6 15"></polyline>
            </svg>
          </div>
        </details>
      </div>
    </div>
  </body>
</html>
